| The current position: | Home |
|
Recently, following the settling of project of Jiangsu Tiandi Renhe Pharmaceutical Co., Ltd. invested by Shaanxi Synthetic Pharmaceutical Co., Ltd. in Taizhou National Medical Hi-tech Development Zone, there have been 38 nonlocal listing companies investing in medical hi-tech development zone together, among which 14 ones are transnational groups, 6 ones are listed in Hong Kong Exchanges and 18 ones are listed in Shanghai Stock Exchange (Shenzhen Stock Exchange).
While attracting nonlocal listing companies, medical hi-tech development zone has focused on propelling listing work of companies in the zone. "Listing is the only road for companies to complete market financing and realize expansion rapidly, is an effective way for companies to build exterior image and strengthen internal quality, and is an objective requirement to promote spanning development of regional economy and intensify comprehensive competitive power," said Lu Chunyun, a member of the Taizhou Municipal Party Standing Committee and Secretary of the Party Working Committee of Taizhou National Medical Hi-tech Development Zone. Moreover, medical hi-tech development zone will seize the opportunity of the country's accelerating constructing multi-level capital market, rapidly set off a new upsurge of listing of companies, realize new breakthrough in company listing, and facilitate economic transformation and upgrade and integrative development in the zone.